FDA Inspection 1050331 — Takeda Pharamaceutical Company Limited
The FDA completed an inspection of Takeda Pharamaceutical Company Limited on Apr 10, 2018 in Longmont, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 10, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Longmont, CO (United States)